IDEXX Laboratories (IDXX) Revenue — Quarter Ended Sep 30, 2023
Revenue for the reporting quarter declined compared with the immediately preceding quarter, but rose compared with the same quarter one year ago. The sequential decrease reflects a moderation from the prior period's growth, while the year-over-year increase indicates continued expansion.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue for the reporting quarter declined compared with the immediately preceding quarter, but rose compared with the same quarter one year ago. The sequential decrease reflects a moderation from the prior period's growth, while the year-over-year increase indicates continued expansion.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$915.5M
Revenue reported for this quarter.
Quarter-over-quarter
-3.0%
Change from the immediately preceding quarter.
Year-over-year
+8.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $828.6M | +3.4% |
| Mar 31, 2023 | $900.2M | +7.6% |
| Jun 30, 2023 | $943.6M | +9.7% |
| Sep 30, 2023 | $915.5M | +8.8% |
Revenue performance
The revenue trajectory shows a decline from the prior quarter, following a period of sequential gains. Compared with the year-ago quarter, the reported revenue is higher, maintaining a positive annual trend.
Quarterly comparison
Revenue in the reporting quarter was lower than the prior quarter, but higher than the same quarter one year earlier. The sequential decline reverses the prior quarter's increase, while the year-over-year gain continues the pattern of annual growth.
What to watch
Monitor trends in companion animal healthcare and distributor purchasing and inventories, as referenced in the filing's business overview.